Propidium Iodide Solution

Pricing & Availability
Other Names
Ave. Rating
Submit a Review
Product Citations
Cat # Size Price Quantity Avail. Save
421301 2 mL 36€
Check Availability

Need larger quantities of this item?
Request Bulk Quote

Propidium iodide (PI) is a fluorescent dye that binds to DNA. When excited by 488nm laser light, it can be detected with in the PE/Texas Red® channel with a bandpass filter 610/10. It is commonly used in evaluation of cell viability or DNA content in cell cycle analysis by flow cytometry.

Product Details
Technical Data Sheet (pdf)

Product Details

Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide.
0.5 mg/ml
Storage & Handling
The solution should be stored undiluted between 2°C and 8°C, and protect from light. Caution: This solution contains hazardous material; handle with care.

FC - Quality tested

Recommended Usage

The suggested use of this solution for viability staining is 10 µl per million cells in 0.5 ml/test, and incubate for 15 minutes at 4 °C before analysis. For Cell Cycle analysis, please see our Propidium Iodide Cell Cycle Staining Protocol. Caution: This solution is toxigenic and mutagenic; handle with care.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Propidium Iodide Solution can be used in evaluation of apoptosis, cell viability and cell cycle analysis by flow cytometry.

Application References
  1. Vermes I, et al.1995. J. Immunol. Methods 184:39.
  2. Darzynkiewicz Z, et al. 1992. Cytometry 13(8):795.
  3. Douglas RS, et al. 1995. J. Immunol. Methods 188:219.
  4. Sakimoto I, et al. 2006. Cancer Research 66:2287.PubMed
  5. Liu H, et al. 2012. Int J Biochem Cell Biol. 45:408. PubMed
  6. Juel HB, et al. 2013. PLoS One. 8:64619. PubMed
  7. Ren Q, et al. 2013. PLoS One. 8:74732. PubMed
  8. Zhao W, et al. 2013. Clin Immunol. 149:119. PubMed
  9. Beggs KM, et al. 2014. Toxicol Sci. 137:91. PubMed
  10. Ewald SE, et al. 2014. Infect Immun. 82:460. PubMed
  11. Tsou WI, et al. 2014. J Biol Chem. 289:25750. PubMed
  12. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
Product Citations
  1. Sakimoto I, et al. 2006. Cancer Res. 66:2287. PubMed
  2. Liu H, et al. 2012. Int J Biochem Cell Biol. 45:408. PubMed
  3. Juel H, et al. 2013. PLoS One. 8:64619. PubMed
  4. Ren Q, et al. 2013. PLoS One. 8:74732. PubMed
  5. Zhao W, et al. 2013. Clin Immunol. 149:119. PubMed
  6. Beggs K, et al. 2014. Toxicol Sci. 137:91. PubMed
  7. Ewald S, et al. 2014. Infect Immun . 82:460. PubMed
  8. Tsou W, et al. 2014. J Biol Chem. 289:25750. PubMed
  9. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
  10. Sapanidou V, et al. 2015. Theriogenology. . PubMed
  11. Mensen A, et al. 2015. Biol Blood Marrow Transplant. Available online 10 August 2015. PubMed
  12. Bao W, et al. 2016. Sci Rep. 6:22579. PubMed
  13. Namas R, et al. 2016. Lupus Sci Med. 3: e000148. PubMed
  14. O'Neill K, et al. 2016. Genes Dev. 30: 973-988. PubMed
  15. Li Y, et al. 2016. Int J Lower Extrem Wounds. 10.1177/1534734616649485. PubMed
  16. Feng L, et al. 2016. J Cell Sci. 129: 2202 - 2212. PubMed
  17. Mahmoudi M, et al. 2016. Sci Rep. 6:26960. PubMed
  18. Chen Y, et al. 2016. J Biol Chem. 291: 13216 - 13228. PubMed
  19. Lange N, et al. 2016. PLoS One. 11: 0160843. PubMed
  20. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  21. Vickman R, et al. 2016. Mol Cancer Res. 14: 776 - 786. PubMed
  22. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  23. Xu B, et al. 2016. Leukemia. 10.1038/leu.2016.297. PubMed
  24. Oubaha M, et al. 2016. Sci Transl Med. 8: 362ra144. PubMed
  25. Schrier S, et al. 2016. Sci Rep. 6:34942. PubMed
  26. Resch U, et al. 2016. MBio. 7: e00207-16. PubMed
  27. L Chang, Y Li, D Kaplan 2016. Sci Rep. 6:36862. PubMed
  28. Guo H, et al. 2016. Sci Rep. 6:37559. PubMed
  29. Polk A, et al. 2016. Clin Cancer Res. 22(24):6118-6128. PubMed
  30. Hughes K, et al. 2017. Open Bio. 10.1098/rsob.160155. PubMed
  31. Domenis R, et al. 2017. PLoS One. 10.1371/journal.pone.0169932. PubMed
  32. Smith A, et al. 2017. Sci Rep. 7:41872. PubMed
  33. Wang C, et al. 2017. Drug Deliv. 10.1080/10717544.2017.1293195. PubMed
  34. Siddhartha V, et al. 2017. Artif Cells Nanomed Biotechnol . 10.1080/21691401.2017.1313267. PubMed
  35. Viseshakul N, et al. 2017. Parasitol Res. 10.1007/s00436-017-5589-5. PubMed
  36. Liu Y, et al. 2017. Acta Biomater. 10.1016/j.actbio.2017.08.021. PubMed
  37. Xie M, et al. 2017. BMC Cancer . 10.1186/s12885-017-3291-8. PubMed
  38. Basso-Ricci L, et al. 2017. Cytometry A. 10.1002/cyto.a.23148. PubMed
  39. Yang X, et al. 2017. J Control Release. 10.1016/j.jconrel.2017.07.014. PubMed
  40. El-Hafeez A, et al. 2017. Cytotechnology. 10.1007/s10616-017-0116-1. PubMed
  41. El-Hafeez A, et al. 2017. Cytotechnology. 10.1007/s10616-017-0124-1. PubMed
  42. Chan J, et al. 2017. Oncogene. 10.1038/onc.2017.319. PubMed
  43. Hosokawa T, et al. 2017. J Immunol. 10.4049/jimmunol.1700157. PubMed
  44. Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
  45. Litzenburger UM, et al. 2017. Genome Biol. 18:15. PubMed
  46. Jung E, et al. 2017. J Neurosci. 37:6837. PubMed
  47. Zhang M, et al. 2017. Oncol Lett. 3.069444444. PubMed
  48. Huang K, et al. 2018. Biol Open. 7:bio029470. PubMed
  49. Li L, et al. 2018. Oncol Lett. 4.184722222. PubMed
  50. Bjørnstad R, et al. 2019. Mol Cancer Ther. 1.14375. PubMed
  51. Li W, et al. 2019. Aging (Albany NY). 0.99375. PubMed
  52. Uroda T, et al. 2019. Mol Cell. 75:982. PubMed
  53. Diaz Osterman CJ, et al. 2019. Elife. 8:e47327. PubMed
  54. Wang Y, et al. 2019. Cell. 179:1144. PubMed
  55. Wang H, et al. 2019. Nat Commun. 4.388194444. PubMed
  56. Popa S, et al. 2020. Wellcome Open Res. 0.249305556. PubMed
  57. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  58. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  59. Neumann CKA, et al. 2020. Mol Metab. 34:136. PubMed
  60. He Y, et al. 2020. Nat Commun. 11:1996. PubMed
  61. Lei W, et al. 2020. Sci Rep. 10:7004. PubMed
  62. Liu L, et al. 2019. Cell Prolif. :e12718. PubMed

Antigen Details

Biology Area
Cell Biology, Cell Cycle/DNA Replication, Neuroscience
Gene ID

Related FAQs

Why is washing not recommended after the addition 7-AAD or PI addition when assessing viability?

These dyes bind in equilibrium with DNA. Therefore, external dye concentration must be maintained during analysis and the dye should not be washed out.

Go To Top Version: 2    Revision Date: 10/08/2015

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.


*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.


BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Insert Note Here
Save Close Clear
Lab Timer
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account